Aclaris Therapeutics, Inc. (LON:0H8T)
London flag London · Delayed Price · Currency is GBP · Price in USD
1.940
-0.085 (-4.20%)
At close: Sep 12, 2025

Aclaris Therapeutics Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
14421258872657203
Upgrade
Market Cap Growth
80.93%263.06%-93.30%32.58%223.25%244.36%
Upgrade
Enterprise Value
1376-87668480175
Upgrade
Last Close Price
1.361.920.8312.3610.625.13
Upgrade
PS Ratio
11.7114.182.3835.30131.6742.84
Upgrade
PB Ratio
1.491.710.475.324.517.38
Upgrade
P/TBV Ratio
1.491.710.475.514.689.10
Upgrade
EV/Sales Ratio
1.055.06-27.0496.0936.79
Upgrade
Debt / Equity Ratio
0.020.020.020.010.020.38
Upgrade
Asset Turnover
0.100.090.140.120.040.08
Upgrade
Quick Ratio
3.733.883.869.948.383.69
Upgrade
Current Ratio
3.883.994.1610.568.943.87
Upgrade
Return on Equity (ROE)
-101.41%-84.46%-49.88%-44.01%-77.33%-95.12%
Upgrade
Return on Assets (ROA)
-20.86%-15.72%-31.67%-21.04%-25.38%-35.87%
Upgrade
Return on Capital (ROIC)
-26.98%-20.59%-39.70%-26.60%-32.43%-48.16%
Upgrade
Earnings Yield
-68.48%-49.76%-118.96%-8.28%-10.21%-18.37%
Upgrade
FCF Yield
-5.11%-7.61%-107.07%-6.49%-5.89%-14.08%
Upgrade
Buyback Yield / Dilution
-44.96%-10.73%-7.05%-14.95%-33.36%-2.94%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.